Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy
Condition(s):Multiple MyelomaLast Updated:August 19, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:August 19, 2014Completed
Condition(s):Multiple MyelomaLast Updated:August 22, 2018Terminated
Condition(s):Multiple MyelomaLast Updated:August 9, 2021Terminated
Condition(s):Multiple MyelomaLast Updated:May 16, 2023Active, not recruiting
Condition(s):Multiple MyelomaLast Updated:May 2, 2017Unknown status
Condition(s):Multiple MyelomaLast Updated:January 10, 2024Recruiting
Condition(s):Multiple MyelomaLast Updated:January 11, 2022Not yet recruiting
Condition(s):Multiple MyelomaLast Updated:February 20, 2013Withdrawn
Condition(s):Multiple MyelomaLast Updated:April 5, 2022Recruiting
Condition(s):Multiple MyelomaLast Updated:December 2, 2020Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.